Crosstalk Between PD-1/PD-L1 Blockade and Its Combinatorial Therapies in Tumor Immune Microenvironment: A Focus on HNSCC
Author:
Publisher
Frontiers Media SA
Subject
Cancer Research,Oncology
Reference133 articles.
1. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012;Ferlay;Int J Cancer,2015
2. Current Treatment Options for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
3. NCCN guidelines insights: head and neck cancers, version 2;Adelstein;J Natl Compr Canc Netw.,2017
4. Nivolumab for recurrent squamous-cell carcinoma of the head and neck;Ferris;N Engl J Med.,2016
5. Cancer immunoediting from immune surveillance to immune escape;Kim;Immunology,2007
Cited by 30 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Novel therapeutic agents in clinical trials: emerging approaches in cancer therapy;Discover Oncology;2024-08-11
2. An Acid-Responsive Iron-Based Nanocomposite for OSCC Treatment;Journal of Dental Research;2024-04-29
3. Tertiary Lymphoid Structures Gene Signature Predicts Prognosis and Immune Infiltration Analysis in Head and Neck Squamous Cell Carcinoma;Current Genomics;2024-03
4. Construction of a pH-responsive nanoreactor and its specific inhibition of oral squamous cell carcinoma growth via TME and xCT/GSH/GPX4 axis;2023-10-18
5. Modulation of PD‑L1 expression by standard therapy in head and neck cancer cell lines and exosomes;International Journal of Oncology;2023-07-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3